Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.332,24
-0,88%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Enochian Biosciences Inc (ENOB) Enochian Biosciences Inc (ENOB) Notizie

Enochian Biosciences Inc

ENOB
0,72
0,00 (0,00%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202422:49EDGAR2Form 8-K - Current report
24/4/202423:23EDGAR2Form 8-K/A - Current report: [Amend]
08/4/202423:44EDGAR2Form SC 13D/A - General statement of acquisition of..
19/3/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/3/202420:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/3/202420:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/3/202414:30EDGAR2Form 8-K - Current report
17/2/202400:11EDGAR2Form SC 13D/A - General statement of acquisition of..
16/2/202421:03EDGAR2Form SC 13D/A - General statement of acquisition of..
16/2/202415:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202414:35EDGAR2Form 8-K - Current report
16/2/202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202423:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/2/202422:33EDGAR2Form 8-K - Current report
07/2/202422:51EDGAR2Form 8-K - Current report
25/1/202423:15EDGAR2Form 8-K - Current report
24/1/202422:08EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:08EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:07EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:07EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:06EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:05EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:05EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:04EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:04EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:03EDGAR2Form SC 13D/A - General statement of acquisition of..
16/1/202423:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
16/1/202423:23EDGAR2Form 8-K - Current report
16/1/202414:06EDGAR2Form 8-K - Current report
16/1/202414:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/1/202414:00EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
22/12/202323:25EDGAR2Form PREM14A - Preliminary proxy statements relating to..
22/12/202317:57EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/12/202323:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/12/202323:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/12/202323:27EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/12/202323:09EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/12/202323:08EDGAR2Form 8-K - Current report
22/11/202322:55EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/11/202322:25EDGAR2Form SC 13D/A - General statement of acquisition of..
02/11/202322:29EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/10/202314:15EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
27/10/202316:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202316:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/10/202303:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/10/202319:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202316:13EDGAR2Form 8-K - Current report
11/10/202315:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
Apertura: Min: Max:
Chiusura: 0,72

La tua Cronologia

NASDAQ
ENOB
Enochian Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network